In the October 2014 issue of Financier Worldwide, CRA Principal Kim Schenk and other industry experts discuss the latest trends in patent disputes around the world and how to resolve them. To read the article, click the link below
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...